| Description |
Sessions on:
Acute Stroke: February 16, 2009
Finding and treating the penumbra / Future trials and clinical decisions based on
DEFUSE and EPITHET results - Jeffrey L. Saver
Is CTA/CTP ready for prime time?
rt-PA: history of development, FDA approval, & subsequent quagmires - Justin Zivin
Current update on acute trials: IMS III, Fast Mag, MR RESCUE, TNK - Steven Levine
Debate/Panel: What is the current best diagnostic paradigm for acute stroke?
Louis Caplan / Jeffrey L. Saver / David Tanne / Steven Levine
What is the current treatment of ICH in light of recent trial results?
Prevention: February 17, 2009
What to do after a TIA? - Louis Caplan
Overview and optimizing stroke prevention strategies - David Tanne
Debate/Panel: Medical vs. interventional management of intracranial stenosis -
Louis Caplan / David Tanne
Ongoing stroke prevention trials - Nathan Bornstein
Evidence-based guidelines to prevent complications after stroke
Rehabilitation
Role of functional MRI in understanding mechanisms of brain recovery
Evidence-based guidelines for the post-stroke patient's recovery
Current clinical trials in stroke rehabilitation
Experimental: February 16, 2009
New approaches to acute stroke treatment - Justin Zivin
Infections of the Nervous System: February 17, 2009
Parallel Sessions - Israel Steiner, Chairman
PML - Joe Berger
Lyme disease - Andy Pachner
Post infectious CNS disorders - Israel Steiner
The role of viral infection in Guillain Barre syndrome - Itzik Wirguin
Controversies in bacterial meningitis: when to do an LP, when to use steroids etc.
The possible viral etiology of MS
Epilepsy: February 16, 2009
Parallel Sessions - Ilan Blatt, Chairman
Meet the Professors: breakout sessions / workshops
Bring challenging cases to and hear challenging cases from the Professors
|
|
